Current treatment options for treating OPA1-mutant dominant optic atrophy.

Abstract excerpt

Dominant optic atrophy (DOA) is caused by OPA1 gene mutation, and it represents one of the most frequently diagnosed forms of hereditary optic neuropathies. This neurodegenerative disorder typically occurs in the first decades of life, and it is often associated with severe visual impairment. For this reason, several treatment options have been examined for the management of DOA, including vitamin supplements,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Therapy
• Share to GTP Phosphohydrolases
• Share to Mutation